Concepts (287)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Calcium | 73 | 2023 | 231 | 11.120 |
Why?
|
| Muscle, Skeletal | 52 | 2023 | 101 | 9.920 |
Why?
|
| Calcium Signaling | 32 | 2018 | 76 | 5.910 |
Why?
|
| Sarcoplasmic Reticulum | 37 | 2017 | 124 | 4.560 |
Why?
|
| Animals | 90 | 2023 | 1050 | 3.750 |
Why?
|
| Calsequestrin | 13 | 2017 | 26 | 3.020 |
Why?
|
| Malignant Hyperthermia | 5 | 2023 | 16 | 2.790 |
Why?
|
| Ryanodine Receptor Calcium Release Channel | 24 | 2023 | 84 | 2.720 |
Why?
|
| Muscle Contraction | 16 | 2023 | 41 | 2.510 |
Why?
|
| Muscle Fibers, Skeletal | 21 | 2023 | 35 | 2.500 |
Why?
|
| Calcium Channels | 24 | 2019 | 77 | 1.880 |
Why?
|
| Caffeine | 11 | 2023 | 30 | 1.680 |
Why?
|
| Myocardium | 13 | 2017 | 53 | 1.570 |
Why?
|
| Membrane Potentials | 29 | 2013 | 97 | 1.570 |
Why?
|
| Myocytes, Cardiac | 8 | 2018 | 41 | 1.560 |
Why?
|
| Muscles | 15 | 2006 | 39 | 1.550 |
Why?
|
| Ion Channel Gating | 19 | 2017 | 57 | 1.490 |
Why?
|
| Hyperglycemia | 2 | 2023 | 9 | 1.390 |
Why?
|
| Mice | 22 | 2022 | 343 | 1.380 |
Why?
|
| Microscopy, Confocal | 17 | 2013 | 32 | 1.360 |
Why?
|
| Rana pipiens | 31 | 2012 | 47 | 1.290 |
Why?
|
| Models, Biological | 20 | 2013 | 110 | 1.070 |
Why?
|
| Fluorescent Dyes | 7 | 2013 | 18 | 0.930 |
Why?
|
| Humans | 20 | 2023 | 2957 | 0.890 |
Why?
|
| Cytosol | 10 | 2012 | 23 | 0.830 |
Why?
|
| Glucose | 2 | 2023 | 10 | 0.820 |
Why?
|
| Cell Membrane | 8 | 2011 | 36 | 0.810 |
Why?
|
| Computer Simulation | 4 | 2019 | 37 | 0.780 |
Why?
|
| Halothane | 2 | 2023 | 6 | 0.760 |
Why?
|
| Myosin Heavy Chains | 1 | 2022 | 4 | 0.740 |
Why?
|
| In Vitro Techniques | 21 | 2012 | 72 | 0.730 |
Why?
|
| Patch-Clamp Techniques | 20 | 2011 | 49 | 0.710 |
Why?
|
| Homeostasis | 3 | 2012 | 17 | 0.700 |
Why?
|
| Excitation Contraction Coupling | 3 | 2017 | 8 | 0.670 |
Why?
|
| Diabetes Mellitus | 1 | 2020 | 10 | 0.630 |
Why?
|
| Myocardial Contraction | 4 | 2015 | 21 | 0.620 |
Why?
|
| Muscle Fibers, Fast-Twitch | 3 | 2012 | 6 | 0.610 |
Why?
|
| Signal Transduction | 7 | 2018 | 97 | 0.590 |
Why?
|
| Cells, Cultured | 12 | 2018 | 119 | 0.580 |
Why?
|
| Monte Carlo Method | 1 | 2019 | 8 | 0.580 |
Why?
|
| Calcium Channels, L-Type | 5 | 2015 | 32 | 0.580 |
Why?
|
| Microscopy, Fluorescence | 5 | 2022 | 21 | 0.570 |
Why?
|
| Muscular Diseases | 2 | 2015 | 9 | 0.560 |
Why?
|
| Calcium-Binding Proteins | 3 | 2015 | 16 | 0.540 |
Why?
|
| Electrophysiology | 19 | 2008 | 55 | 0.530 |
Why?
|
| Disease Susceptibility | 3 | 2023 | 14 | 0.520 |
Why?
|
| Cell Membrane Permeability | 4 | 2011 | 18 | 0.510 |
Why?
|
| Action Potentials | 8 | 2013 | 44 | 0.470 |
Why?
|
| Kinetics | 14 | 2013 | 63 | 0.470 |
Why?
|
| Cardiomyopathies | 1 | 2015 | 3 | 0.450 |
Why?
|
| Biosensing Techniques | 2 | 2011 | 6 | 0.430 |
Why?
|
| Membrane Proteins | 2 | 2023 | 18 | 0.430 |
Why?
|
| Carrier Proteins | 2 | 2015 | 13 | 0.410 |
Why?
|
| Muscle Proteins | 2 | 2015 | 18 | 0.410 |
Why?
|
| Ryanodine | 2 | 2012 | 14 | 0.410 |
Why?
|
| Hypothermia | 1 | 2013 | 3 | 0.390 |
Why?
|
| Pyridinium Compounds | 1 | 2013 | 3 | 0.390 |
Why?
|
| Neurons | 1 | 2012 | 55 | 0.370 |
Why?
|
| Rats | 11 | 2016 | 234 | 0.350 |
Why?
|
| Electric Stimulation | 11 | 2004 | 25 | 0.330 |
Why?
|
| Adult | 5 | 2020 | 794 | 0.330 |
Why?
|
| Protein Isoforms | 5 | 2022 | 7 | 0.320 |
Why?
|
| Algorithms | 7 | 2017 | 52 | 0.300 |
Why?
|
| Rabbits | 9 | 2013 | 70 | 0.280 |
Why?
|
| Central Nervous System Stimulants | 3 | 2000 | 19 | 0.280 |
Why?
|
| Protein Binding | 3 | 2019 | 25 | 0.280 |
Why?
|
| Feedback, Physiological | 1 | 2008 | 3 | 0.270 |
Why?
|
| Ion Channels | 4 | 2009 | 58 | 0.260 |
Why?
|
| Magnesium | 6 | 2012 | 24 | 0.250 |
Why?
|
| Mammals | 2 | 2023 | 6 | 0.250 |
Why?
|
| Kidney | 3 | 2003 | 13 | 0.240 |
Why?
|
| Mutation | 3 | 2015 | 77 | 0.230 |
Why?
|
| Phosphorylation | 4 | 2020 | 28 | 0.230 |
Why?
|
| Image Enhancement | 1 | 2005 | 5 | 0.230 |
Why?
|
| Sodium Compounds | 3 | 1993 | 4 | 0.230 |
Why?
|
| Perchlorates | 3 | 1993 | 5 | 0.230 |
Why?
|
| Neuromuscular Junction | 3 | 2009 | 3 | 0.220 |
Why?
|
| Male | 4 | 2018 | 1860 | 0.220 |
Why?
|
| Heart | 3 | 2003 | 16 | 0.210 |
Why?
|
| Dose-Response Relationship, Drug | 4 | 2018 | 85 | 0.210 |
Why?
|
| Mice, Knockout | 4 | 2010 | 67 | 0.210 |
Why?
|
| Calcium Channel Blockers | 3 | 2010 | 15 | 0.210 |
Why?
|
| Rats, Sprague-Dawley | 6 | 2007 | 161 | 0.200 |
Why?
|
| Heart Ventricles | 3 | 2013 | 23 | 0.190 |
Why?
|
| Egtazic Acid | 7 | 2011 | 9 | 0.190 |
Why?
|
| Glycogen Synthase Kinase 3 beta | 1 | 2023 | 4 | 0.190 |
Why?
|
| Calcium, Dietary | 1 | 2023 | 9 | 0.190 |
Why?
|
| Protein Processing, Post-Translational | 2 | 2016 | 5 | 0.190 |
Why?
|
| Tetracaine | 5 | 2007 | 8 | 0.190 |
Why?
|
| Neoplasms, Unknown Primary | 1 | 2002 | 1 | 0.180 |
Why?
|
| Adenocarcinoma | 1 | 2002 | 3 | 0.180 |
Why?
|
| Purpura, Thrombotic Thrombocytopenic | 1 | 2002 | 2 | 0.180 |
Why?
|
| Stomach Neoplasms | 1 | 2002 | 5 | 0.180 |
Why?
|
| Bone Marrow | 1 | 2002 | 21 | 0.180 |
Why?
|
| Time Factors | 5 | 2005 | 208 | 0.170 |
Why?
|
| Isoproterenol | 2 | 2013 | 10 | 0.160 |
Why?
|
| Adrenergic beta-Agonists | 2 | 2013 | 8 | 0.160 |
Why?
|
| Phosphorylase Kinase | 1 | 2020 | 3 | 0.160 |
Why?
|
| Glycogen Phosphorylase, Muscle Form | 1 | 2020 | 3 | 0.160 |
Why?
|
| Glucose Transporter Type 4 | 1 | 2020 | 3 | 0.160 |
Why?
|
| Glycogen | 1 | 2020 | 6 | 0.160 |
Why?
|
| Anura | 4 | 2004 | 13 | 0.160 |
Why?
|
| Middle Aged | 2 | 2020 | 792 | 0.160 |
Why?
|
| Blood Glucose | 1 | 2020 | 20 | 0.160 |
Why?
|
| Aged | 2 | 2020 | 956 | 0.150 |
Why?
|
| Dihydropyridines | 3 | 1998 | 5 | 0.150 |
Why?
|
| Female | 3 | 2018 | 1724 | 0.150 |
Why?
|
| Cytoplasm | 2 | 2013 | 11 | 0.150 |
Why?
|
| Phenotype | 2 | 2017 | 75 | 0.140 |
Why?
|
| Anesthetics, Inhalation | 1 | 2018 | 7 | 0.140 |
Why?
|
| Purpura, Thrombocytopenic, Idiopathic | 1 | 2017 | 1 | 0.130 |
Why?
|
| Disease Models, Animal | 3 | 2013 | 174 | 0.130 |
Why?
|
| Synaptic Transmission | 2 | 1993 | 7 | 0.130 |
Why?
|
| Species Specificity | 3 | 2005 | 10 | 0.120 |
Why?
|
| Image Processing, Computer-Assisted | 2 | 2012 | 24 | 0.120 |
Why?
|
| Inositol 1,4,5-Trisphosphate | 2 | 1997 | 8 | 0.120 |
Why?
|
| Mitochondrial Proteins | 1 | 2015 | 4 | 0.120 |
Why?
|
| Mutation, Missense | 1 | 2015 | 7 | 0.120 |
Why?
|
| Electric Conductivity | 5 | 1997 | 45 | 0.110 |
Why?
|
| Barium | 4 | 1998 | 7 | 0.110 |
Why?
|
| Hydrogen-Ion Concentration | 4 | 2009 | 32 | 0.110 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2015 | 92 | 0.110 |
Why?
|
| Intracellular Membranes | 2 | 1991 | 9 | 0.110 |
Why?
|
| Sarcoplasmic Reticulum Calcium-Transporting ATPases | 2 | 2010 | 10 | 0.100 |
Why?
|
| Amyotrophic Lateral Sclerosis | 2 | 2011 | 3 | 0.100 |
Why?
|
| Fluorescence | 1 | 2013 | 4 | 0.100 |
Why?
|
| Gene Deletion | 1 | 2012 | 12 | 0.090 |
Why?
|
| Protein Kinase C | 1 | 1992 | 16 | 0.090 |
Why?
|
| Binding Sites | 2 | 2009 | 12 | 0.090 |
Why?
|
| Muscle, Smooth, Vascular | 1 | 1992 | 2 | 0.090 |
Why?
|
| Ventricular Function | 1 | 1992 | 4 | 0.090 |
Why?
|
| Cell Line | 3 | 2003 | 56 | 0.090 |
Why?
|
| Models, Cardiovascular | 1 | 2012 | 5 | 0.090 |
Why?
|
| Cats | 1 | 2012 | 6 | 0.090 |
Why?
|
| Biophysical Phenomena | 2 | 2002 | 16 | 0.090 |
Why?
|
| Biophysics | 2 | 2002 | 20 | 0.090 |
Why?
|
| Nitrendipine | 1 | 1991 | 2 | 0.090 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2012 | 33 | 0.090 |
Why?
|
| Muscle Cells | 1 | 2011 | 4 | 0.090 |
Why?
|
| Ligands | 1 | 2011 | 9 | 0.090 |
Why?
|
| Mitochondria, Muscle | 1 | 2011 | 2 | 0.090 |
Why?
|
| Sensory Receptor Cells | 1 | 1991 | 1 | 0.090 |
Why?
|
| Saponins | 2 | 2006 | 2 | 0.090 |
Why?
|
| Second Messenger Systems | 1 | 1991 | 3 | 0.080 |
Why?
|
| Xanthenes | 3 | 2000 | 3 | 0.080 |
Why?
|
| Aniline Compounds | 3 | 2000 | 7 | 0.080 |
Why?
|
| Buffers | 1 | 2010 | 5 | 0.080 |
Why?
|
| Gene Expression | 1 | 2010 | 45 | 0.080 |
Why?
|
| Feedback | 3 | 1997 | 11 | 0.080 |
Why?
|
| Intracellular Space | 1 | 2009 | 2 | 0.080 |
Why?
|
| Mitochondria | 1 | 2009 | 12 | 0.080 |
Why?
|
| Phagocytosis | 1 | 2009 | 5 | 0.080 |
Why?
|
| Metals, Alkali | 1 | 1989 | 1 | 0.080 |
Why?
|
| Metals, Alkaline Earth | 1 | 1989 | 1 | 0.080 |
Why?
|
| Neutrophils | 1 | 2009 | 16 | 0.080 |
Why?
|
| Guinea Pigs | 3 | 1993 | 17 | 0.070 |
Why?
|
| Basophils | 1 | 2008 | 3 | 0.070 |
Why?
|
| Immunoglobulin E | 1 | 2008 | 3 | 0.070 |
Why?
|
| Proton Pumps | 1 | 2008 | 3 | 0.070 |
Why?
|
| Hypersensitivity | 1 | 2008 | 5 | 0.070 |
Why?
|
| Chelating Agents | 2 | 2011 | 6 | 0.070 |
Why?
|
| Lipid Bilayers | 4 | 2003 | 31 | 0.070 |
Why?
|
| Diffusion | 1 | 2008 | 11 | 0.070 |
Why?
|
| Down-Regulation | 1 | 2008 | 22 | 0.070 |
Why?
|
| Predictive Value of Tests | 1 | 2008 | 50 | 0.070 |
Why?
|
| Ranidae | 3 | 1991 | 3 | 0.060 |
Why?
|
| Receptors, Adrenergic, beta | 1 | 2007 | 4 | 0.060 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinases | 1 | 2007 | 10 | 0.060 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 1 | 2007 | 15 | 0.060 |
Why?
|
| Biological Transport | 2 | 1999 | 13 | 0.060 |
Why?
|
| Markov Chains | 2 | 2002 | 7 | 0.060 |
Why?
|
| Thermodynamics | 2 | 2002 | 17 | 0.060 |
Why?
|
| Sulfates | 1 | 2005 | 1 | 0.060 |
Why?
|
| Solutions | 1 | 2005 | 8 | 0.060 |
Why?
|
| Glutamic Acid | 1 | 2005 | 6 | 0.060 |
Why?
|
| Tissue Distribution | 1 | 2005 | 2 | 0.060 |
Why?
|
| Organelles | 1 | 2005 | 2 | 0.060 |
Why?
|
| Image Interpretation, Computer-Assisted | 1 | 2005 | 15 | 0.060 |
Why?
|
| Naphthalenesulfonates | 1 | 2004 | 1 | 0.050 |
Why?
|
| Phenolsulfonphthalein | 1 | 2004 | 1 | 0.050 |
Why?
|
| Coloring Agents | 1 | 2004 | 3 | 0.050 |
Why?
|
| Phosphodiesterase Inhibitors | 2 | 2003 | 3 | 0.050 |
Why?
|
| Electromagnetic Fields | 1 | 2003 | 1 | 0.050 |
Why?
|
| Adaptation, Physiological | 1 | 2003 | 19 | 0.050 |
Why?
|
| Extracellular Space | 2 | 1996 | 6 | 0.050 |
Why?
|
| Oscillometry | 1 | 2002 | 3 | 0.050 |
Why?
|
| Models, Statistical | 1 | 2002 | 27 | 0.050 |
Why?
|
| Biomarkers | 2 | 2017 | 101 | 0.050 |
Why?
|
| Probability | 2 | 1992 | 7 | 0.050 |
Why?
|
| Necrosis | 1 | 2002 | 2 | 0.040 |
Why?
|
| Fatal Outcome | 1 | 2002 | 3 | 0.040 |
Why?
|
| Fever | 1 | 2002 | 10 | 0.040 |
Why?
|
| Pain | 1 | 2002 | 47 | 0.040 |
Why?
|
| Osmolar Concentration | 1 | 2000 | 8 | 0.040 |
Why?
|
| Muscle Development | 1 | 1999 | 1 | 0.040 |
Why?
|
| Artifacts | 1 | 1999 | 2 | 0.040 |
Why?
|
| Benzopyrans | 2 | 2009 | 6 | 0.040 |
Why?
|
| Diastole | 2 | 2010 | 14 | 0.040 |
Why?
|
| Xenopus | 1 | 1998 | 4 | 0.040 |
Why?
|
| Cloning, Molecular | 1 | 1998 | 6 | 0.040 |
Why?
|
| Rana catesbeiana | 1 | 1998 | 6 | 0.040 |
Why?
|
| DNA, Complementary | 1 | 1998 | 5 | 0.040 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 1998 | 6 | 0.040 |
Why?
|
| Base Sequence | 1 | 1998 | 24 | 0.040 |
Why?
|
| Molecular Sequence Data | 1 | 1998 | 31 | 0.040 |
Why?
|
| Amino Acid Sequence | 1 | 1998 | 31 | 0.040 |
Why?
|
| Polymerase Chain Reaction | 1 | 1998 | 19 | 0.040 |
Why?
|
| RNA, Messenger | 1 | 1998 | 59 | 0.040 |
Why?
|
| Mice, Inbred BALB C | 1 | 2017 | 16 | 0.030 |
Why?
|
| Platelet Count | 1 | 2017 | 3 | 0.030 |
Why?
|
| Spain | 1 | 2017 | 2 | 0.030 |
Why?
|
| Immunoglobulins, Intravenous | 1 | 2017 | 2 | 0.030 |
Why?
|
| Hemorrhage | 1 | 2017 | 9 | 0.030 |
Why?
|
| Registries | 1 | 2017 | 22 | 0.030 |
Why?
|
| Disease Management | 1 | 2017 | 16 | 0.030 |
Why?
|
| Comorbidity | 1 | 2017 | 49 | 0.030 |
Why?
|
| Adrenal Cortex Hormones | 1 | 2017 | 16 | 0.030 |
Why?
|
| Anesthetics, Local | 1 | 1997 | 30 | 0.030 |
Why?
|
| Child, Preschool | 1 | 2017 | 119 | 0.030 |
Why?
|
| Infant | 1 | 2017 | 122 | 0.030 |
Why?
|
| Acetylglucosamine | 1 | 2016 | 1 | 0.030 |
Why?
|
| Mannose | 1 | 2016 | 1 | 0.030 |
Why?
|
| Glycosylation | 1 | 2016 | 5 | 0.030 |
Why?
|
| Cattle | 1 | 2016 | 17 | 0.030 |
Why?
|
| Sodium | 2 | 1997 | 16 | 0.030 |
Why?
|
| Young Adult | 1 | 2017 | 187 | 0.030 |
Why?
|
| Child | 1 | 2017 | 197 | 0.030 |
Why?
|
| Perfusion | 1 | 1996 | 5 | 0.030 |
Why?
|
| Treatment Outcome | 1 | 2017 | 186 | 0.030 |
Why?
|
| Adolescent | 1 | 2017 | 247 | 0.030 |
Why?
|
| Rana esculenta | 1 | 1996 | 1 | 0.030 |
Why?
|
| Amino Acid Substitution | 1 | 2015 | 3 | 0.030 |
Why?
|
| Protein Structure, Tertiary | 1 | 2015 | 6 | 0.030 |
Why?
|
| Protein Structure, Secondary | 1 | 2015 | 7 | 0.030 |
Why?
|
| Crystallography, X-Ray | 1 | 2015 | 8 | 0.030 |
Why?
|
| Membranes | 1 | 1995 | 6 | 0.030 |
Why?
|
| Ion Transport | 1 | 1994 | 13 | 0.030 |
Why?
|
| Chlorides | 1 | 1994 | 9 | 0.030 |
Why?
|
| Cadmium | 1 | 1993 | 2 | 0.030 |
Why?
|
| Edetic Acid | 1 | 1993 | 1 | 0.030 |
Why?
|
| Isradipine | 1 | 1993 | 2 | 0.030 |
Why?
|
| Calcium Radioisotopes | 1 | 1993 | 2 | 0.030 |
Why?
|
| Allosteric Regulation | 1 | 1993 | 2 | 0.030 |
Why?
|
| Stimulation, Chemical | 1 | 1993 | 2 | 0.030 |
Why?
|
| Cations | 1 | 1993 | 3 | 0.030 |
Why?
|
| Transfection | 2 | 2007 | 19 | 0.020 |
Why?
|
| Macromolecular Substances | 1 | 1992 | 4 | 0.020 |
Why?
|
| Protein Kinases | 1 | 1992 | 3 | 0.020 |
Why?
|
| Gallopamil | 1 | 1992 | 6 | 0.020 |
Why?
|
| Sodium Channels | 1 | 1992 | 7 | 0.020 |
Why?
|
| Mathematics | 1 | 1991 | 19 | 0.020 |
Why?
|
| Mice, Mutant Strains | 1 | 2011 | 5 | 0.020 |
Why?
|
| Ruthenium Red | 1 | 1991 | 6 | 0.020 |
Why?
|
| Receptors, Nicotinic | 1 | 1991 | 3 | 0.020 |
Why?
|
| Receptors, Cholinergic | 1 | 1991 | 8 | 0.020 |
Why?
|
| Biomechanical Phenomena | 1 | 1991 | 95 | 0.020 |
Why?
|
| Mitochondria, Heart | 1 | 2010 | 2 | 0.020 |
Why?
|
| Ventricular Dysfunction, Left | 1 | 2010 | 3 | 0.020 |
Why?
|
| Carbonyl Cyanide p-Trifluoromethoxyphenylhydrazone | 1 | 2009 | 1 | 0.020 |
Why?
|
| Ruthenium Compounds | 1 | 2009 | 2 | 0.020 |
Why?
|
| Stress, Physiological | 1 | 2009 | 2 | 0.020 |
Why?
|
| Membrane Potential, Mitochondrial | 1 | 2009 | 2 | 0.020 |
Why?
|
| Naphthols | 1 | 2009 | 3 | 0.020 |
Why?
|
| Sodium-Hydrogen Exchangers | 1 | 2009 | 3 | 0.020 |
Why?
|
| Protons | 1 | 2009 | 4 | 0.020 |
Why?
|
| Rhodamines | 1 | 2009 | 4 | 0.020 |
Why?
|
| NADPH Oxidases | 1 | 2009 | 4 | 0.020 |
Why?
|
| Muscle Relaxation | 1 | 1989 | 1 | 0.020 |
Why?
|
| Antibodies, Anti-Idiotypic | 1 | 2008 | 3 | 0.020 |
Why?
|
| N-Formylmethionine Leucyl-Phenylalanine | 1 | 2008 | 3 | 0.020 |
Why?
|
| Proton Pump Inhibitors | 1 | 2008 | 3 | 0.020 |
Why?
|
| Tetradecanoylphorbol Acetate | 1 | 2008 | 6 | 0.020 |
Why?
|
| Histamine | 1 | 2008 | 5 | 0.020 |
Why?
|
| Zinc | 1 | 2008 | 9 | 0.020 |
Why?
|
| Colforsin | 1 | 2007 | 4 | 0.020 |
Why?
|
| Isoquinolines | 1 | 2007 | 5 | 0.020 |
Why?
|
| Calmodulin | 1 | 2007 | 5 | 0.020 |
Why?
|
| Benzylamines | 1 | 2007 | 11 | 0.020 |
Why?
|
| Sulfonamides | 1 | 2007 | 9 | 0.020 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinase Type 2 | 1 | 2007 | 10 | 0.020 |
Why?
|
| Peptides | 1 | 2007 | 19 | 0.020 |
Why?
|
| Heart Failure | 1 | 2007 | 16 | 0.020 |
Why?
|
| Swine | 1 | 2003 | 12 | 0.010 |
Why?
|
| Potassium | 1 | 2003 | 14 | 0.010 |
Why?
|
| Calibration | 1 | 2002 | 3 | 0.010 |
Why?
|
| Biotransformation | 1 | 1997 | 2 | 0.010 |
Why?
|
| Myofibrils | 1 | 1988 | 4 | 0.000 |
Why?
|